Arun Swaminathan

Arun Swaminathan

Chief Executive Officer, DirectoratCoya Therapeutics· In proxies 2023–2025

Pay in FY2025+40% from the year before · Coya Therapeutics stock +1.2% the same year

Arun Swaminathan was paid $2.1M in FY2025 (Dec), up 40%. Coya Therapeutics stock rose 1.2% that year.

Pay$100 in the stock at the end of FY22 → $122
Pay is from the Summary Compensation Table of each Coya Therapeutics proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Coya TherapeuticsPublic company · 3 yr
    • Chief Executive Officer, Director2023 – Present · 3 yrStock in role -14%

Roles come from the proxy statements of each company.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?